Merck, invests € 35 million in biosafety testing at its Glasgow and Stirling sites, Scotland. Biosafety testing is a critical step in the drug development Responds to global demand for biosafety testing for drug development and commercialization Expansion creates nearly 500 new jobs in Glasgow and Stirling Company’s investment to boost global testing capacity now […]
ST. PAUL, Minn. — Applying its leadership in biopharma filtration technology, 3M (NYSE: MMM) today announced it will invest $146 million dollars to expand its capabilities to further support biotech manufacturing, a fast-growing area of health care which is bringing breakthrough therapies to patients. The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing […]
Full Spectrum Lab Services from CBRE offers extensive capabilities across industries CBRE Group, Inc. (NYSE: CBRE) announced a new brand Full Spectrum Lab Services from CBRE. For decades, CBRE has offered lab-specific services, including laboratory design and productivity consulting, lab equipment relocation, calibration maintenance, and repair, primarily for bio-pharma clients. With the recent acquisition of Full […]
Company will use its deep technology expertise to deliver actionable phenotypic data for tissue profiling studies MENLO PARK, Calif. — Ionpath, a pioneer in high-definition spatial proteomics, today announced a rebalancing of the company’s focus toward its Spatial Proteomics Services. The company will suspend sales of its multiplexed ion beam imaging (MIBI™) technology as a […]
GMP Facility Expected to Simplify the mRNA Drug Substance Development Process; Slated to Welcome Customers in Early 2024 SAN DIEGO –TriLink BioTechnologies (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has announced the expansion of its mRNA manufacturing capabilities to serve late-phase drug developers. TriLink’s construction of the new 32,000-square-foot, cGMP-grade […]
Facility will have capacity that exceeds today’s global plasmid DNA demand and can enable commercialisation of genetic medicines. Transformation of Grade II-listed Victorian waterworks on the River Thames in Hampton, London. Supplying many of the top biopharmaceutical companies in the world to dramatically enhance their ability to develop genetic medicines. Expansion follows recent acceptance of a Drug […]
New branding reflects customer-centric approach and showcases pioneering, single cell analysis technology Rebrand follows a period of significant growth for the Company, including key leadership team appointments, state-of-the-art facility expansion, and new scientific partnerships Cambridge, UK: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, today announced the introduction of […]
Framingham, MA — SCIEX, a global leader in life science analytical technologies, celebrates the opening of the Echo® MS Center of Excellence. The center builds on the SCIEX culture of innovation and features a world-class demonstration laboratory that will serve as a portal to building strategic customer collaborations. The center is outfitted with two automation solutions, each coupled to […]
Avantor Commits to Setting Near-Term Emission Reduction Targets in Support of Science Based Targets initiative RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today released its 2023 Sustainability Report, highlighting progress made in 2022 implementing environment, […]
– Precision diagnostics crucial for targeted cancer treatment Qlucore, a company listed on Nasdaq First North, is in the process of obtaining CE certification for its cancer diagnostic software. The company has contracted the British Standards Institution (BSI) as the Notified Body to conduct the Conformity Assessment of Qlucore Diagnostics‘ acute lymphoblastic leukemia devices. BSI […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
